Theratechnologies submits tesamorelin MAA in Brazil
Tesamorelin is intended as a treatment for excess abdominal fat in HIV-infected patients with lipodystrophy. Earlier in December 2010, Theratechnologies has given license to an affiliate of Sanofi
miRecule has signed a research collaboration with EM subsidiary Rio Biofarma Brasil (RBBL) to co-develop peptide-mediated delivery technologies aimed at improving targeted ribonucleic acid (RNA) therapeutics delivery to tissues beyond the liver and muscles in a range of disease areas.
PrimeMobile incorporates functionality accessed on handheld devices with Greenway’s single-database electronic health record (EHR), practice management and interoperability solution – PrimeSuite. PrimeMobile’s administrative and financial capabilities integrate charge